Related Research Articles
The Scandinavian Simvastatin Survival Study, was a multicentre, randomized, double-blind, placebo-controlled clinical trial, which provided the initial data that supported the use of the cholesterol-lowering drug, simvastatin, in people with a moderately raised cholesterol and coronary heart disease (CHD); that is people who had previously had a heart attack or angina. The study was sponsored by the pharmaceutical company Merck and enrolled 4,444 people from 94 centres in Scandinavia.
Cardiovascular disease (CVD) is any disease involving the heart or blood vessels. CVDs constitute a class of diseases that includes: coronary artery diseases, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, thromboembolic disease, and venous thrombosis.
The Heart Protection Study was a randomized controlled trial run by the Clinical Trial Service Unit, and funded by the Medical Research Council (MRC) and the British Heart Foundation (BHF) in the United Kingdom. It studied the use of the cholesterol lowering drug, simvastatin 40 mg and vitamin supplementation in people who were at risk of cardiovascular disease. It was led by Jane Armitage, an epidemiologist at the Clinical Trial Service Unit.
Indapamide is a thiazide-like diuretic drug used in the treatment of hypertension, as well as decompensated heart failure. Combination preparations with perindopril are available. The thiazide-like diuretics reduce risk of major cardiovascular events and heart failure in hypertensive patients compared with hydrochlorothiazide with a comparable incidence of adverse events. Both thiazide diuretics and thiazide-like diuretics are effective in reducing risk of stroke. Both drug classes appear to have comparable rates of adverse effects as other antihypertensives such as angiotensin II receptor blockers and dihydropyridine calcium channel blockers and lesser prevalence of side-effects when compared to ACE-inhibitors and non-dihydropyridine calcium channel blockers.
The British Doctors' Study was a prospective cohort study which ran from 1951 to 2001, and in 1956 provided convincing statistical evidence that tobacco smoking increases risk of lung cancer.
A case–control study is a type of observational study in which two existing groups differing in outcome are identified and compared on the basis of some supposed causal attribute. Case–control studies are often used to identify factors that may contribute to a medical condition by comparing subjects who have the condition with patients who do not have the condition but are otherwise similar. They require fewer resources but provide less evidence for causal inference than a randomized controlled trial. A case–control study is often used to produce an odds ratio. Some statistical methods make it possible to use a case–control study to also estimate relative risk, risk differences, and other quantities.
Sir Austin Bradford Hill was an English epidemiologist who pioneered the modern randomised clinical trial and, together with Richard Doll, demonstrated the connection between cigarette smoking and lung cancer. Hill is widely known for pioneering the "Bradford Hill" criteria for determining a causal association.
Sir William Richard Shaboe Doll was a British physician who became an epidemiologist in the mid-20th century and made important contributions to that discipline. He was a pioneer in research linking smoking to health problems. With Ernst Wynder, Bradford Hill and Evarts Graham, he was credited with being the first to prove that smoking increased the risk of lung cancer and heart disease.
Edrecolomab is a mouse-derived monoclonal antibody targeting the cell-surface glycoprotein EpCAM (17-1A), which is expressed on epithelial tissues and on various carcinomas.
Sarah C. Darby is Professor of Medical Statistics at the University of Oxford. Her research has focused the beneficial effects of smoking cessation, the risk of lung cancer from residential radon, and treatments for early breast cancer. She is also a Principal Scientist with the Cancer Research UK in the Clinical Trial Service Unit (CTSU) and Epidemiological Studies Unit at the Nuffield Department of Clinical Medicine, at the Radcliffe Infirmary, Oxford.
Sir Rory Edwards Collins FMedSci FRS is a British physician who is Professor of Medicine and Epidemiology at the Clinical Trial Service Unit within the University of Oxford, the head of the Nuffield Department of Population Health and a Fellow of Green Templeton College, Oxford. His work has been in the establishment of large-scale epidemiological studies of the causes, prevention and treatment of heart attacks, other vascular disease, and cancer, while also being closely involved in developing approaches to the combination of results from related studies ("meta-analyses"). Since September 2005, he has been the Principal Investigator and Chief Executive of the UK Biobank, a prospective study of 500,000 British people aged 40–69 at recruitment.
Dame Valerie Beral AC DBE FRS FRCOG FMedSci was an Australian-born British epidemiologist, academic and a preeminent specialist in breast cancer epidemiology. She was Professor of Epidemiology, a Fellow of Green Templeton College, Oxford and was the Head of the Cancer Epidemiology Unit at the University of Oxford and Cancer Research UK from 1989.
The International Studies of Infarct Survival (ISIS) were four randomized controlled trials of several drugs for treating suspected acute myocardial infarction. More than 134,000 patients from over 20 countries took part in four large simple trials between 1981 and 1993, coordinated from Oxford, England.
The Lumleian Lectures are a series of annual lectures started in 1582 by the Royal College of Physicians and currently run by the Lumleian Trust. The name commemorates John Lumley, 1st Baron Lumley, who with Richard Caldwell of the College endowed the lectures, initially confined to surgery, but now on general medicine. William Harvey did not announce his work on the circulation of the blood in the Lumleian Lecture for 1616 although he had some partial notes on the heart and blood which led to the discovery of the circulation ten years later. By that time ambitious plans for a full anatomy course based on weekly lectures had been scaled back to a lecture three times a year.
Targeted intra-operative radiotherapy, also known as targeted IORT, is a technique of giving radiotherapy to the tissues surrounding a cancer after its surgical removal, a form of intraoperative radiation therapy. The technique was designed in 1998 at the University College London.
The Bradshaw Lectures are lectureships given at the invitation of the Royal College of Physicians and the Royal College of Surgeons of England. It is held on alternate years in rotation with the Hunterian Oration.
Susan Ann Jebb is Chair of the United Kingdom's Food Standards Agency and Professor of Diet and Population Health at the Nuffield Department of Primary Care Health Sciences, University of Oxford.
Colin Baigent is a British academic physician and cardiovascular epidemiologist. He is a professor of epidemiology, Director of the Medical Research Council Population Health Research Unit at the University of Oxford, and deputy director of the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), part of Oxford Population Health. His work is focused in the design and coordination of large-scale randomised trials and the use of meta-analysis to assess the efficacy and safety of drugs for the prevention of cardiovascular disease (CVD) or premature death.
The Randomised Evaluation of COVID-19 Therapy is a large-enrollment clinical trial of possible treatments for people in the United Kingdom admitted to hospital with severe COVID-19 infection. The trial was later expanded to Indonesia, Nepal and Vietnam. The trial has tested ten interventions on adults: eight repurposed drugs, one newly developed drug and convalescent plasma.
Sir Martin Jonathan Landray is a British physician, epidemiologist and data scientist who serves as a Professor of Medicine & Epidemiology at the University of Oxford. Landray designs, conducts and analyses large-scale randomised control trials; including practice-changing international trials that have recruited over 100,000 individuals. Landray previously led the health informatics team that enabled the collection and management of data for the UK Biobank on over half a million people.
References
- 1 2 3 4 Anon (2017). "Peto, Sir Richard" . Who's Who (online Oxford University Press ed.). Oxford: A & C Black. doi:10.1093/ww/9780199540884.013.30686.(Subscription or UK public library membership required.)
- ↑ "Professor Richard PETO | Jeantet". 1 October 2017.
- ↑ Knottnerus, J. A. (2008). "The Dr A.H. Heineken Prize for Medicine 2008 awarded to Sir Richard Peto". Nederlands Tijdschrift voor Geneeskunde. 152 (41): 2216–2218. PMID 19009807.
- ↑ Mann, C. (1990). "Richard Peto: Statistician with a Mission". Science. 249 (4968): 479. doi:10.1126/science.249.4968.479. PMID 17735279. Archived from the original on 21 November 2014. Retrieved 7 August 2012.
- ↑ "Royal Society citation".
- ↑ "Experts Examined - Sir Richard Peto". 13 June 2005 – via news.bbc.co.uk.
- ↑ "The Life Scientific - Richard Peto on why smoking kills but quitting saves lives - BBC Sounds". bbc.co.uk.
- ↑ "Sir Richard Peto". University of Oxford. Archived from the original on 2 August 2017. Retrieved 26 December 2012.
- ↑ "Yale University: Honorary Degrees". USA: Yale University. Archived from the original on 21 May 2015. Retrieved 26 December 2012.
- ↑ "Sasi's Thai". Find The Company. UK. Retrieved 24 May 2015.[ permanent dead link ]
